Opportunity
Federal Register #2026-06928
Final Results of Expedited Second Sunset Reviews of Antidumping Duty Orders on Monosodium Glutamate from Indonesia and China
Posted
April 10, 2026
Identifier
2026-06928
This notice announces the final results of expedited second sunset reviews by the U.S. Department of Commerce, International Trade Administration, concerning antidumping duty orders on monosodium glutamate (MSG) from Indonesia and China. - Government Buyer: - U.S. Department of Commerce - International Trade Administration - OEMs and Vendors Mentioned: - Ajinomoto Health & Nutrition North America, Inc. (domestic interested party) - Products/Services: - Monosodium glutamate (MSG) - No part numbers or quantities specified (regulatory review, not a procurement) - Unique or Notable Requirements: - Review determined that revoking antidumping orders would likely result in continued or renewed dumping - Weighted-average dumping margins up to 6.19% for Indonesia and 40.41% for China - No substantive response from respondent interested parties - Notice references original antidumping orders and review process - This is a regulatory action, not a solicitation for goods or services
Description
The U.S. Department of Commerce has determined that revoking the antidumping duty orders on monosodium glutamate (MSG) from Indonesia and China would likely lead to the continuation or recurrence of dumping. The final results indicate weighted-average dumping margins up to 6.19% for Indonesia and 40.41% for China. This determination follows an expedited sunset review process initiated in October 2025, with no substantive response from respondent interested parties.